1. Red-hot biotechs to take spotlight at ASH virtual meeting — Moderna's 3-month data raise hopes for COVID-19 vaccine durability — BioNTech founder vaults into world's 500 richest — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Biden And Trump Drug Pricing Policies Would Decimate Biotech, Drive Innovation To China

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 23, 2020 at 11:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    18,045
    Likes Received:
    3
    via Both parties (Republicans, Democrats) would replace today’s market-driven system, which bases prices on the value of the product to the consumer, with controlled prices tied to those in countries where governments set reimbursement rates substantially lower than here. The resulting drop in revenue for the pharmaceutical industry would kill innovation in the U.S. and Europe and cripple the biotech community.

    article source